BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2024 7:12:19 AM | Browse: 330 | Download: 1324
 |
Received |
|
2024-06-27 09:01 |
|
Peer-Review Started |
|
2024-06-27 09:01 |
|
First Decision by Editorial Office Director |
|
2024-08-16 05:48 |
|
Return for Revision |
|
2024-08-18 16:08 |
|
Revised |
|
2024-08-28 16:53 |
|
Publication Fee Transferred |
|
2024-09-14 06:06 |
|
Second Decision by Editor |
|
2024-09-12 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-09-12 07:14 |
|
Articles in Press |
|
2024-09-12 07:14 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-10-09 06:16 |
|
Publish the Manuscript Online |
|
2024-10-14 07:12 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Recent efficacy and long-term survival of Astragalus polysaccharide combined with gemcitabine and S-1 in pancreatic cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Guang-Yu Li and Jing Jiang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jing Jiang, PhD, Professor, Department of Hepatopancreatobiliary Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, No. 1 East Banshan Road, Hangzhou 310000, Zhejiang Province, China. jjsgxhszlyy@gmail.com |
| Key Words |
Pancreatic cancer; Astragalus polysaccharide; Long-term survival; Immune function; Traditional Chinese medicine |
| Core Tip |
Astragalus polysaccharide (APS) plays an active role in the treatment of malignant tumors based on traditional Chinese medicine (TCM). This study analyzed the effects of the combined therapy of APS and gemcitabine plus tegafur gimeracil oteracil potassium capsule (S-1) in the treatment of pancreatic cancer, showing improved objective response rate and disease control rate, increased CD4+ T cells and serum interleukin-2 levels, and prolonged median survival time. The findings demonstrated the potential of APS as an effective TCM-based treatment option in pancreatic cancer therapies. |
| Publish Date |
2024-10-14 07:12 |
| Citation |
Li GY, Jiang J. Recent efficacy and long-term survival of Astragalus polysaccharide combined with gemcitabine and S-1 in pancreatic cancer. World J Clin Oncol 2024; 15(11): 1404-1411
|
| URL |
https://www.wjgnet.com/2218-4333/full/v15/i11/1404.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v15.i11.1404 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
